Knee Assessment | Smart Health Innovation Lab

A Conversation With Emovi About KneeKG and the Smart Health Certification Program

Earlier this year, the Montreal-based healthcare technology company Emovi began commercialization of their innovative, non-invasive knee assessment device KneeKG, which has the potential to revolutionize knee care and lower costs. With $5 million in capital raised thus far, Emovi (which stands for emotion, movement, and vision) aims to transform the complete knee care pathway to achieve better outcomes at lower costs. Since their pre-commercial launch of KneeKG, their device has already been used to assess thousands of patients in eight countries at facilities such as Hospital Cochin in France, Centre de Médecine Sportive de Laval in Canada, and Saxony Health Hospital in Indiana, USA. This year they joined the Smart Health Certification Program in June as an inaugural class member, and were selected as one of 50 companies featured in the 2018 MedTech Innovator showcase.

KneeKG is the first device that enables in-clinic, dynamic, 3D knee assessments of patients while they are in motion and in weight-bearing conditions. It provides kinematic information to doctors critical to identifying specific pathologic patterns and developing a focused treatment strategy to restore optimal knee function. Emovi says their device can result in a number of benefits, including reduced pain, recovery time, opioid intake, number of interventions and cost per patient.

We are thrilled to have Emovi as an inaugural class member of the Smart Health Certification Program. We believe KneeKG could have a big impact in orthopedics, pain management, and preventative care, and we’ve been working closely with the Emovi team to overcome the challenges associated with integrating into a major health system and gaining insurance reimbursement.

We recently sat down with the Emovi team to discuss their experiences at the Smart Health Innovation Lab.

Why did your company choose to participate in the Smart Health Certification Program?

The Smart Health Certification Program is totally unique and probably the only program that creates a fast-track to clinical adoption and integration. To us, that was an extremely valuable proposition that we couldn’t pass up.

What have you gained so far from working with the Innovation Lab?

Working with the Smart Health Innovation Lab has helped us address some critical components needed to scale the deployment of KneeKG. They helped us uncover and overcome some HIPAA compliance challenges, assisted us with EHR integration, and introduced us to an expansive network of solid contacts.

How do you think this program will impact your company’s roadmap? What do you hope to gain after graduation?

In addition to achieving privacy compliance and EHR integration, the Smart Health Innovation Lab is providing validation of our product offering, workflow, and value. The integration blueprint that is being developed in concert with Penn Medicine Lancaster General Health and Capital BlueCross will help us replicate the integration process into other health systems and insurance reimbursement models, ultimately helping us scale our business.

What makes our program unique?

Not only does the program create a fast track to clinical adoption and integration, but it is also full of dynamic, capable and motivated people who have rolled up their sleeves to help us accelerate our path to market adoption.

How do you hope to change healthcare for the better? Do you think the Innovation Lab can help other companies make a positive change in healthcare?

We anticipate transforming knee care in the United States and the rest of the world. KneeKG can make a big impact on healthcare by addressing the Quadruple Aim – positively affecting patient experiences and outcomes, improving provider satisfaction, improving population health and reducing costs. We believe the Innovation Lab’s guidance and validation will positively influence the future of medical devices, by helping transformative companies like Emovi and NeuroFlow gain a stronger foothold in the market.

* * *

Emovi will celebrate their graduation from the Smart Health Certification Program, along with NeuroFlow, on October 4, 2018. We have been honored to work with such innovative companies for our inaugural class, and we believe both companies are positioned to make a positive impact on care. Our next Smart Health Certification Program will begin in January, 2019.

At the Smart Health Innovation Lab, we aim to inspire innovation in everything we do.

Q&A: A Conversation With NeuroFlow About Smart Health Certification

Founded in 2016 in Philadelphia, Pa., NeuroFlow is poised to make a big impact on healthcare. The company acquired its first paying client during the beta-testing phase of its product in August 2017, and raised $1.25 million in institutional capital by October. It launched its first commercial, fully-operational product in March 2018, joined the Smart Health Certification Program in June, and reached 100 paying clients in four countries shortly thereafter. NeuroFlow has won a variety of awards, including Psych Congress’ Best New Technology 2018, Philadelphia magazine’s 10 Startups to Watch 2018, Philly’s realLIST 2018 of top start-ups, and MedTech Boston’s top 5 mental health technology companies.

NeuroFlow’s HIPAA-compliant, cloud-based software platforms empower healthcare providers to objectively assess, track, and engage patients using evidence-based practices to support their mental health remotely, throughout all of therapy, not just during clinical visits; the platforms also empower patients to be accountable for their improvement and engagement in the therapy process, which is paramount for successful outcomes. Their suite of tools enables remote monitoring and behavioral health integration across the continuum of care, including psychology, primary care, and pain management settings. EngageBH assists behavioral health specialists in enhancing evidence-based therapies, improving engagement and compliance with therapy assignments; and IntegrateHealth seamlessly integrates behavioral health assessments and tracking into primary care and pain management settings. Combined, NeuroFlow’s platforms not only help clinicians and providers save costs, but also — more importantly — they help patients feel better.

We are proud to have NeuroFlow as a member of our inaugural class in the Smart Health Certification Program. We see broad potential applications for their technology, and we’re helping them build a blueprint for integrating into health systems to gain enterprise-level customers. We’re also facilitating critical conversations around insurance reimbursement that could offer NeuroFlow a major advantage in the future.

We recently sat down with Adam Pardes, COO of NeuroFlow to discuss their involvement in the Lab.

What is NeuroFlow’s core mission?

Healthcare providers are our heroes. They’re responsible for helping those who need it most, which can be a tough challenge when patients struggle with mental health conditions, often resulting in poor engagement, motivation, and treatment compliance.

NeuroFlow’s mission is to be a resource and asset to healthcare providers in their tireless pursuit to help patients feel better faster.

Why did your company choose to participate in the Smart Health Certification Program?

The program set us on a collision course with two vital aspects of the healthcare ecosystem: payors and providers. The Smart Health Innovation Lab is a collaborative environment where our technology has been able to make an immediate impact. We felt we had scaled our technology to be effective in a large-scale healthcare provider, and here we are today, in over 100 clinics and hospitals with thousands of patients using the platform.

What have you gained so far from working with the Innovation Lab?

This has been an invaluable experience for all of us working at NeuroFlow. To be able to tinker and tailor our product with real-time feedback from clinical professionals has given us the greenlight on future opportunities at major healthcare providers. We knew our product was capable of supporting clinical decision making, but this has been further validation, and more importantly, evidence that it could work in large health systems. We have been given several pathways to success, with doors opened by members of the Smart Health Innovation Lab ecosystem.

How do you think this program will impact your company’s roadmap? What do you hope to gain after graduation?

NeuroFlow grew 183% in the two quarters preceding the program. During the summer months, in the midst of the program, the company experienced 700% growth and has several more large hospital systems inquiring about using NeuroFlow’s unique and powerful tools with their providers and their patients. The program helped validate our product’s usability at scale in a large health system, and has thus accelerated our company’s growth and expansion. We will be making several key hires on the product side before the end of 2018. By adding new features and making it interoperable with major EHRs, we’re poised to make an even bigger impact with more patients and providers at large systems like Penn Medicine Lancaster General Hospital.

What makes our program unique?

The physical lab environment created is truly comprehensive — from the workstations to the product demo rooms built to replicate a hospital or clinical therapy setting. We have not seen anything like it, and it has been an opportunity to debut our software across the healthcare spectrum with leading experts in each discipline serving as a focus group. It has been a great second office to call a home away from our home in Center City Philadelphia.

How do you hope to change healthcare for the better? Do you think the Innovation Lab can help other companies make a positive change in healthcare?

Far too many people struggle with depression, anxiety, and PTSD. Millions of Americans are diagnosed but never seek treatment, or do so but find it to be ineffective. The good news is that there are evidence based therapies, such as cognitive behavioral therapy (CBT), that are proven to work and be effective — there’s hope. These do not have to be chronic conditions. The challenge is that they work predicated on the patient’s engagement, compliance, and willingness to be an owner of the process. We believe NeuroFlow can help this and integrate behavioral health into the primary healthcare conversation.

With the resources, expertise, and access available as virtue of the Smart Health Innovation Lab, the program has helped prove that new, innovative technologies can deliver value to large health systems. We wholeheartedly recommend the program to other healthcare technology start-ups at similar stages of growth. It will serve as a learning experience and creative environment to try new things and to scale your ability to meet your company’s mission.